Langhans giant cells from M. Tuberculosis-induced human granulomas cannot mediate mycobacterial uptake

Journal of Pathology

Volumn 211, Issue 1, 2007, Pages 76-85

  Lay, G ^a   Poquet, Y ^a   Salek Peyron, P ^a   Puissegur, M P ^a   Botanch, C ^a   Bon, H ^a   Levillain, F ^a   Duteyrat, J L ^b   Emile, J F ^c   Altare, Frederic ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b CHU RANGUEIL   (France)

^c HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Giant cells; Multinucleate cells; Mycobacteria; Tuberculosis; Uptake

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANTIGEN PRESENTATION; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; CELL COUNT; CELL DIFFERENTIATION; CONTROLLED STUDY; DENDRITIC CELL; GIANT CELL; GRANULOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LANGHANS GIANT CELL; MACROPHAGE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUBERCULOSIS;

ANTIGEN-PRESENTING CELLS; AXILLA; BCG VACCINE; FLOW CYTOMETRY; GIANT CELLS; GIANT CELLS, LANGHANS; GRANULOMA, GIANT CELL; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MICROSCOPY, CONFOCAL; MYCOBACTERIUM TUBERCULOSIS; NADP; PHAGOCYTOSIS; SPECIES SPECIFICITY; STAINING AND LABELING; TUBERCULOSIS; VIRULENCE;

EID: 33846254553     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2092     Document Type: Article

References (35)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione M. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence and mortality by country. WHO Global Surveillance and Monitoring Project. J Am Med Assoc 1999;282:677-686.
2. World Health Organisation. Global Tuberculosis Control, WHO Report. [November 2006] http://www.who.int/mediacentre/factsheets/fsl04/en/ index.html[2001].
3. Glickman MS, Jacobs WR Jr. Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline. Cell 2001;104:477-495.
4. Tufariello JM, Chan J, Flynn JL. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect Dis 2003;3:578-590.
5. Saunders BM, Cooper AM. Restraining mycobacteria. Role of granulomas in mycobacterial infections. Immunol Cell Biol 2000;78:334-341.
6. Toossi Z, Ellner JJ. Pathogenesis of tuberculosis. In Tuberculosis, Friedman LN (ed). CRC Press:New York, 2001; 19-47.
7. Saunders BM, Frank AA, Orme IM. Granuloma formation is required to contain bacillus growth and delay mortality in mice chronically infected with Mycobacterium tuberculosis. Immunology 1999;98:324-328.
8. Sandor M, Weinstock JV, Wynn TA. Granulomas in schistosome and mycobacterial infections: a model of local immune responses. Trends Immunol 2003;24:44-52.
9. Orme IM. The mouse as a useful model of tuberculosis. Tuberculosis (Edinburgh) 2003;83:112-115.
10. Kaufmann SH. Immune response to tuberculosis: experimental animal models. Tuberculosis (Edinburgh) 2003;83:107-111.
11. Duncan K, Barry CE 3rd. Prospects for new antitubercular drugs. Curr Opin Microbiol 2004;7:460-465.
12. Pozos TC, Ramakrishnan L. New models for the study of Mycobacterium-host interactions. Curr Opin Immunol 2004;16:499-505.
13. Davis JM, Clay H, Lewis JL, Ghori N, Herbomel P, Ramakrishnan L. Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos. Immunity 2002;17:693-702.
14. Volkman HE, Clay H, Beery D, Chang JC, Sherman DR, Ramakrishnan L. Tuberculous granuloma formation is enhanced by a mycobacterium virulence determinant. PLoS Biol 2004;2:e367.
15. Puissegur MP, Botanch C, Duteyrat JL, Delsol G, Caratero C, Altare F. An in vitro dual model of mycobacterial granulomas to investigate the molecular interactions between mycobacteria and human host cells. Cell Microbiol 2004;6:423-433.
16. Ortalo-Magne A, Dupont MA, Lemassu A, Andersen AB, Gounon P, Daffe M. Molecular composition of the outermost capsular material of the tubercle bacillus. Microbiology 1995;141:1609-1620.
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
18. Ulrichs T, Kaufmann SH. New insights into the function of granulomas in human tuberculosis. J Pathol 2006;208:261-269.
19. Emile JF, Patey N, Altare F, Lamhamedi S, Jouanguy E, Boman F et al. Correlation of granuloma structure with clinical outcome defines two types of idiopathic disseminated BCG infection. J Pathol 1997;181:25-30.
20. Altare F, Jouanguy E, Lamhamedi S, Döffinger R, Fischer A, Casanova JL. Mendelian susceptibility to mycobacterial infections in man. Curr Opin Immunol 1998;10:413-417.
21. Altare F. Lammas D, Revy P, Jouanguy E, Döffinger R, Lamhamedi S, et al. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin infection. J Clin Invest 1998;102:2035-2040.
22. Altare F, Fusser A, Breiman A, Reichenbach J, El Baghdadi J, Fischer A, et al. Interleukin-12 receptor β 1 deficiency in a patient with abdominal tuberculosis. J Infect Dis 2001;184:231-236.
23. McNally AK, Anderson JM. Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells. Am J Pathol 1995;147:1487-1499.
24. Dugast C. Gaudin A, Toujas L. Generation of multinucleated giant cells by culture of monocyte-derived macrophages with IL-4. J Leukoc Biol 1997;61:517-521.
25. Enelow RI, Sullivan GW, Carper HT, Mandell GL. Induction of multinucleated giant cell formation from in vitro culture of human monocytes with interleukin-3 and interferon-gamma: comparison with other stimulating factors. Am J Respir Cell Mol Biol 1992;6:57-62.
26. Chambers TJ. Fusion of hamster macrophages induced by lectins. J Pathol 1977;123:53-61.
27. Orentas RJ, Reinlib L, Hildreth JE. Anti-class II MHC antibody induces multinucleated giant cell formation from peripheral blood monocytes. J Leukoc Biol 1992;51:199-209.
28. Tabata N, Ito M, Shimokata K, Suga S, Ohgimoto S, Tsurudome M, et al. Expression of fusion regulatory proteins (FRPs) on human peripheral blood monocytes. Induction of homotypic cell aggregation and formation of multinucleated giant cells by anti-FRP-1 monoclonal antibodies. J Immunol 1994;153:3256-3266.
29. Anderson JM. Multinucleated giant cells. Curr Opin Hematol 2000;7:40-47.
30. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
31. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immunol 2001;2:675-680.
32. Figdor CG, van Kooyk Y, Adema GJ. C-type lectin receptors on dendritic cells and Langerhans cells. Nature Rev Immunol 2002;2:77-84.
33. Inaba K, Pack M, Inaba M, Sakuta H, Isdell F, Steinman RM. High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes. J Exp Med 1997;186:665-672.
34. Devulder G, Perouse de Montclos M, Flandrois JP. A multigene approach to phylogenetic analysis using the genus Mycobacterium as a model. Int J Syst Evol Microbiol 2005;55:293-302.
35. Pym AS, Brodin P, Majlessi L, Brosch R, Demangel C, Williams A, et al. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nature Med 2003;9:533-539.